Documentos
Subtipo de publicación
Bachelor Thesis(7044)
Article(5830)
Other(4740)
Conference Object(1477)
Master Thesis(672)
Publisher
Espol(336)
EFSA Journal(305)
Universidad del Azuay(288)
Universidad Católica de Santiago de Guayaquil(219)
Universidad Casa Grande. Facultad de Comunicación Mónica Herrera(213)
Área temáticas
Dirección general(2317)
Física aplicada(2311)
Enfermedades(1937)
Ciencias de la computación(1785)
Escuelas y sus actividades; educación especial(1512)
Mostrando 10 resultados de: 20352
Safety and efficacy of ‘dry grape extract 60-20’ when used as feed flavouring for dogs
ArticleAbstract: The feed additive ‘dry grape extract 60-20’ is a mixture of two extracts, one from the seed and thePalabras claves:dogs, Efficacy, Example: dry grape extract 60-20, Flavourings, safety, Sensory additiveAutores:Anguita M., Azimonti G., Bampidis V., Bastos M.D.L., Brantom P.G., Chesson A., Christensen H., Durjava. M.K., Dusemund B., Galobart J., Holczknecht O., Kouba M., Manini P., Marcon F., Marta López-Alonso, Mayo B., Pechova A., Petkova M., Pettenati E., Pizzo F., Puente S.L., Ramos F., Sanz Y., Tarres-Call J., Villa R.E., Westendorf J., Woutersen R.Fuentes:scopusSafety and employee health and wellbeing
Book PartAbstract: This chapter explores how to improve integration of safety and health with each other as a necessaryPalabras claves:Autores:Andrei D.M., Griffin M.A., Paola Ochoa PachecoFuentes:googlescopusSafety and feasibility of the Woven EndoBridge device deployment with monitored anesthesia care
ArticleAbstract: Objective: The Woven EndoBridge (WEB) device can be used for complex intracranial aneurysms (IAs), mPalabras claves:Endovascular Treatment, general anesthesia, intracranial aneurysm, monitored anesthesia care, Woven EndoBridgeAutores:Allan L., Hasan D.M., Ishii D., Jorge A. Roa, Li L., Samaniego E.A., Zanaty M.Fuentes:scopusSafety and immunogenicity of a human epidermal growth factor receptor 1 (HER1)-based vaccine in prostate castration-resistant carcinoma patients: A dose-escalation phase I study trial
ArticleAbstract: Metastatic castration-resistant prostate cancer (CRPC) remains incurable due to the lack of effectivPalabras claves:Human epidermal growth factor receptor, Immunogenicity, Prostate cancer, safety, Therapeutic vaccineAutores:Aira L.E., Bárbara Wilkinson, Caballero I., Casacó Parada A.R., Coba K., González J.G., González N., Lavastida A., Luaces P.L.o., Macías A.E., Mazorra Z., Mesa M., Popa X., Rivero J., Sanchez B., Santiesteban Y., Suárez E., Tania Crombet, Troche M.Fuentes:scopusSafety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults
ArticleAbstract: Background: SOBERANA 02 has been evaluated in phase I and IIa studies comparing homologous versus hePalabras claves:Conjugate vaccine, covid-19, heterologous schedule, phase IIb clinical trial, recombinant RBD, Translation to patientsAutores:Acevedo-Martínez Y., Acosta-Martinez M.A., Alfaro-Guzmán A., Amoroto M., Arteaga-García A., Ávila-Cabreja J.A., Baro-Roman G., Bergado-Baez G., Biglari A., Boggiano-Ayo T., Brito-Pascual I., Cardoso-SanJorge F., Chen G.W., Climent-Ruiz Y., Coviella-Artime J.M., Cruz-Sui O., Cubas-Curbelo M., Díaz-Hernández M., Domínguez-Pentón Y.R., Doroud D., Dubed-Echevarría M., Enriquez-Puertas J., Espi-Ávila J., Espino-Rojas N.T., Estoque-Cabrera S., Fernández-Castillo S., Fontanies-Fernández M., Galano-Frutos E., Garcés-Hechavarría A., García-Carmenate M., García-López E., García-Montero M., García-Rivera D., García-Vega Y., Garrido-Arteaga R., Gómez-Maceo Y., González-Mugica R., Guillén-Obregón B., Hernández-Garcia T., Lora-García J., Martínez-Bedoya D., Martínez-Pérez M., Martínez-Rivera R., Medina-Nápoles M., Medinas-Santos G.M., Mendoza-Hernández I., Misladys Rodríguez Ortega, Morales-Ruano S., Morffi-Cinta I., Muñoz Y., Noa-Romero E., Ojito-Magaz E., Ontivero-Pino I., Orosa-Vázquez I., Palenzuela-Diaz A., Paredes-Moreno B., Pérez-Guevara M.T., Perez-Perez A., Pérez-Rodríguez S., Pi-Estopiñán F., Quintero-Moreno L., Ramírez-Gonzalez U., Reyes-Matienzo R., Rivera D.G., Rodríguez-Castillo P.G., Rodriguez-González M., Rodríguez-Noda L., Sanchez-Ramirez B., Santana-Mederos D., Santos-Vega B.L., Sarda-Rodriguez I.L., Toledo-Romani M.E., Valdes-Balbín Y., Valenzuela-Silva C.M., Valera-Fernández R., Verdecia-Sánchez L., Verez-Bencomo V., Zulueta-Pérez L.Fuentes:scopusSafety and immunogenicity of the Cuban heptavalent pneumococcal conjugate vaccine in healthy infants. Results from a double-blind randomized control trial Phase I
OtherAbstract: Background Cuba has a new pneumococcal conjugate vaccine candidate (PCV7-TT). This study evaluates tPalabras claves:Autores:Maria Elena MesaFuentes:googleSafety and long-lasting immunity of the combined administration of a modified-live virus vaccine against porcine reproductive and respiratory syndrome virus 1 and an inactivated vaccine against porcine parvovirus and Erysipelothrix rhusiopathiae in breeding pigs
ArticleAbstract: Background: In the field, vaccination schedules based on modified-live virus (MLV) vaccines administPalabras claves:Cell-mediated immunity, Combined administration of vaccines, Erysipelothrix rhusiopathiae, neutralizing antibodies, Porcine parvovirus, Porcine reproductive and respiratory syndrome virus, Vaccine scheduleAutores:Camprodon A., Jaime E. Maldonado, Miranda J., Pedrazuela R., Sánchez-Matamoros A.Fuentes:scopusSafety and occupational health performance: Intervention model based on accident statistics
ArticleAbstract: The performance of the health and safety management system was analyzed, confronting it with the accPalabras claves:Incident rate, Management systems, occupational healthAutores:Eulalia M. Villa, José E. Obando, Sotolongo M.Fuentes:scopusSafety and preliminary efficacy data of a novel Casein Kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies
ArticleAbstract: Background: Cervical cancer is now considered the second leading cause of death among women worldwidPalabras claves:Autores:Acevedo B.E., Alonso D.F., Baladron I., Castillo D., Díaz A., Gómez R., González C.A., Herrera L., López-Saura P.A., Perea-Rodríguez S.E., Santana A., Sigman H., Solares A.M., Thelvia I. Ramos Gómez, Valenzuela-Silva C.M.Fuentes:googlescopusSafety and tolerability of lapatinib ditosylate given concurrently with docetaxel, carboplatin, and trastuzumab (TCHL) as part of adjuvant therapy for patients with HER2+ …
OtherAbstract: 565 Background: The nonanthracycline regimen of docetaxel (T), carboplatin (C), and trastuzumab (H)Palabras claves:Autores:Alejandra PérezFuentes:google